GleamWall
中文EN

FTLF FITLIFE BRANDS, INC.

Medicinal Chemicals & Botanical Products · Nasdaq · SEC CIK 1374328 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY46.5%
TTM net income YoY1.9%
TTM EPS YoY1.5%
Revenue 3-yr CAGR32.2%
Net income 3-yr CAGR17.1%

Margins

Gross margin36.7%
Operating margin11.0%
Net margin6.7%
FCF margin4.5%
EBITDA margin11.9%

Returns

ROE15.1%
ROA6.4%
ROIC (approx.)13.8%
Asset turnover0.96x

Leverage & solvency

Liabilities / assets53.3%
Debt / equity0.00x
Current ratio1.64x
Interest coverage3.93x

Cash quality & payout

Operating cash flow / net income0.68x
Accruals ratio2.0%
Payout ratio—
Capex / revenue0.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$25.62M$26.55M$25.32M$25.91M$23.48M$16.13M$15.94M$15.01M
Cost of revenue$15.95M$16.74M$15.81M$16.97M$14.75M$9.22M$9.06M$8.80M
Gross profit$9.67M$9.81M$9.52M$8.94M$8.74M$6.90M$6.87M$6.21M
SG&A expense$5.18M$4.75M$4.96M$4.93M$4.11M$2.48M$2.51M$2.29M
Operating income$2.65M$3.35M$3.06M$2.27M$2.32M$2.52M$2.96M$2.88M
Interest expense$654,000$679,000$735,000$814,000$562,000$175,000$244,000$282,000
Pretax income$2.04M$2.68M$2.35M$1.38M$1.75M$2.38M$2.72M$2.65M
Income tax$465,000$734,000$627,000-$258,000$829,000$631,000$701,000$581,000
Net income$1.57M$1.95M$1.72M$1.64M$921,000$1.75M$2.02M$2.07M
EBITDA$2.90M$3.61M$3.31M$2.52M$2.45M$2.53M$2.98M$2.90M
EPS (basic)0.170.210.18—0.100.190.22—
EPS (diluted)0.160.200.17—0.090.180.20—
Weighted avg. shares (diluted)9.91M9.91M9.99M—10.00M9.96M9.93M—
Balance sheet
Cash & equivalents$689,000$1.09M$1.19M$1.65M$3.51M$1.53M$5.94M$4.47M
Receivables$8.05M$6.98M$7.78M$8.77M$9.64M$2.49M$2.69M$1.63M
Inventory$22.74M$21.07M$21.53M$21.32M$22.23M$11.72M$12.13M$11.07M
Current assets$33.62M$30.55M$31.64M$33.07M$37.40M$22.18M$21.76M$18.14M
PP&E, net$52,000$78,000$106,000$128,000$135,000$81,000$89,000$75,000
Goodwill$19.33M$19.33M$19.36M$19.39M$19.37M$13.12M$13.04M$13.02M
Intangibles$50.73M$50.95M$51.20M$51.44M$51.65M$26.29M$26.23M$26.23M
Total assets$105.38M$102.59M$104.27M$106.32M$109.98M$62.85M$62.19M$58.53M
Current liabilities$20.55M$20.91M$20.81M$21.61M$33.02M$12.97M$13.30M$11.31M
Short-term debt————$14.09M——$4.50M
Long-term debt————$32.36M$6.32M$7.44M$8.55M
Total debt————$46.46M$6.32M$7.44M$13.05M
Total liabilities$56.12M$55.22M$58.89M$62.68M$68.09M$21.93M$23.27M$22.41M
Shareholders' equity$49.25M$47.37M$45.38M$43.64M$41.89M$40.92M$38.92M$36.13M
Net debt————$42.95M$4.79M$1.50M$8.58M
Shares outstanding9.39M9.39M9.39M9.39M9.39M9.39M9.38M9.21M
Cash flow statement
Operating cash flow-$1.67M$3.63M$2.48M$244,000$3.67M$1.20M$2.33M$957,000
Capital expenditure$0$0$0$5,000$8,000$5,000$24,000$0
Free cash flow-$1.67M$3.63M$2.48M$239,000$3.66M$1.19M$2.30M$957,000
Investing cash flow$0$0$0-$5,000-$37.51M-$5.00M-$24,000$0
Financing cash flow$1.28M-$3.72M-$2.92M-$1.92M$35.58M-$702,000-$866,000-$1.11M
Depreciation & amortization$250,000$252,000$248,000$251,000$136,000$14,000$19,000$23,000
Stock-based compensation——$17,000———$107,000—

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.